Search
Adjuvant Chemotherapy for Stage III Colon Cancer in Healthy Patients | Gastrointestinal Cancer | Research | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/adjuvant-chemotherapy-colon-cancer/
Researchers at UT Southwestern set out to understand the under-utilization of ACT in stage three colon cancer patients. Learn the impact on patient outcomes here.
Refining Stereotactic Body Radiation Therapy for Breast Cancer | Breast Cancer | Clinical Trials | Patient Care | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/stereotactic-body-radiation-therapy-breast-cancer/
Simmons Cancer Center at UT Southwestern is the first center in Texas and the second center in the world to offer GammaPod treatment for breast cancer. Learn more here.
A Pioneer in Plasma Cell Disorders | Hematologic Malignancies | Patient Care | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/dr-larry-anderson-plasma-cell-disorders/
UT Southwestern has been committed to patient care for more than a decade. Learn about his efforts to advance treatment of plasma cell disorders here.
Cellular Stress Response Promotes Immune Evasion in Lung Cancer | Lung Cancer | Research | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/pd-l1-regulation-mechanism-lung-cancer/
Researchers uncover a key mechanism that regulates PD-L1, a protein that helps tumors evade the immune system and is the target of several immunotherapy drugs.
Novel Drug Combination Fights Resistance to TKI Therapy | Lung Cancer | Research | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/drug-combination-fights-tki-therapy-resistance/
A new drug pairing discovered at the UT Southwestern Simmons Cancer Center might extend the effectiveness of a lung cancer treatment. Learn more now.
New Breakthroughs in Prostate Cancer Treatment | Clinical Trials | Genitourinary Cancer | Patient Care | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/prostate-cancer-breakthrough-2020-treatment/
Cross-disciplinary teams are working to improve the patient experience by mitigating the side effects of surgical treatment and radiation therapy. Learn more here.
Are ED Visits by Cancer Patients Preventable? | Patient Care | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/reducing-ed-visits-cancer-patients/
Oncology patients frequently visit the ED for health concerns — even when it’s not the best fit for their needs. Here’s what we know today about reducing ED visits.
Eliminating Socioeconomic Disparities in Care for Patients with Testicular Cancer | Genitourinary Cancer | Patient Care | Population Science | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/eliminating-socioeconomic-disparities-testicular-cancer-treatment/
Researchers at UT Southwestern are studying the impact of the standardization of care and access to specialized professionals across populations. Here’s the results.
Integrating Basic Science with Clinical Practice | Genitourinary Cancer | Patient Care | Population Science | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/chief-hematology-oncology/
UT Southwestern’s Chief of Hematology and Oncology has a history of pioneering breakthroughs while mentoring strong leaders. Learn more about her story here.
ChIA-PET Sequencing Provides Insight into Prostate Cancer Genomics | Genitourinary Cancer | Research | UT Southwestern Medical Center
https://utswmed.org/cancer/cancer-answers/prostate-cancer-genomics-sequencing/
Leveraging chIA-PET sequencing, researchers at UT Southwestern have discovered findings that could lead to novel prostate cancer therapies. Learn more here.